Results 231 to 240 of about 11,407 (242)
Some of the next articles are maybe not open access.

Comparing Originator Biologics and Biosimilars: A Review of the Relevant Issues

Clinical Therapeutics, 2017
Corrado Blandizzi   +2 more
exaly  

Changes in inflammatory bowel disease patients’ perspectives on biosimilars: A follow‐up survey

United European Gastroenterology Journal, 2019
Laurent Peyrin-Biroulet, Silvio Danese
exaly  

Biosimilars: What the Oncologist should Know

Future Oncology, 2019
Marc Thill, Vladimir Hanes
exaly  

Biosimilars for the treatment of psoriasis

Expert Opinion on Biological Therapy, 2019
L Puig, A Lopez-Ferrer
exaly  

The nocebo effect: a clinical challenge in the era of biosimilars

Expert Review of Clinical Immunology, 2018
Lieven Pouillon   +2 more
exaly  

Comparative Immunogenicity Assessment of Biosimilars

Future Oncology, 2019
Georgios Bakalos
exaly  

Epoetin Biosimilars in Europe: Five Years On

Advances in Therapy, 2012
Ashraf Mikhail   +2 more
exaly  

Biosimilars

International Journal of Pharmaceutical Medicine, 2007
Martin K Kuhlmann   +2 more
openaire   +1 more source

Biosimilars: How Similar are They?

The International Journal of Artificial Organs, 2005
openaire   +3 more sources

Home - About - Disclaimer - Privacy